Literature DB >> 33315069

Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.

Steven Joffe1.   

Abstract

Entities:  

Year:  2021        PMID： 33315069     DOI： 10.1001/jama.2020.25127

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

Review 1.  Health Product Manufacturers and Innovators COVID-19 Impact Assessment: Lessons Learned and Compelling Needs.

Authors:  Mathai Mammen; Vasant Narasimhan; Richard Kuntz; Freda Lewis-Hall; Mojdeh Poul; Adam Schechter
Journal:  NAM Perspect       Date:  2022-01-18

Review 2.  Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines.

Authors:  Annoor Awadasseid; Yanling Wu; Yoshimasa Tanaka; Wen Zhang
Journal:  Biomed Pharmacother       Date:  2021-01-28       Impact factor: 7.419

3.  The Essential Role of Data and Safety Monitoring Boards (DSMBs) in Ensuring the Ethics of Global Vaccine Trials to Address Coronavirus Disease 2019 (COVID-19O).

Authors:  Lisa Eckstein; Annette Rid; Dorcas Kamuya; Seema K Shah
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

4.  COVID-19 Infection Among Women in Iran Exposed vs Unexposed to Children Who Received Attenuated Poliovirus Used in Oral Polio Vaccine.

Authors:  Farrokh Habibzadeh; Mohammad M Sajadi; Konstantin Chumakov; Mahboobeh Yadollahie; Shyamasundaran Kottilil; Ashraf Simi; Kristen Stafford; Saeid Saeidimehr; Mohammad Rafiei; Robert C Gallo
Journal:  JAMA Netw Open       Date:  2021-11-01

Review 5.  Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.

Authors:  Mahender Aileni; Gulab Khan Rohela; Phanikanth Jogam; Shakuntala Soujanya; Baohong Zhang
Journal:  Cells       Date:  2022-03-31       Impact factor: 6.600

6.  Next steps for efficacy evaluation in clinical trials of COVID-19 vaccines.

Authors:  Hu-Dachuan Jiang; Li Zhang; Jing-Xin Li; Feng-Cai Zhu
Journal:  Engineering (Beijing)       Date:  2021-05-19       Impact factor: 7.553

Review 7.  Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic.

Authors:  Nadezhda Ivanova; Yoana Sotirova; Georgi Gavrailov; Krastena Nikolova; Velichka Andonova
Journal:  Pharmaceutics       Date:  2022-02-27       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.